Trident Lifeline Ltd

BSE: 543616 · Pharmaceuticals & Biotechnology · 30 announcements

Share price: ₹394.70
Market cap: ₹465.7 Cr
Revenue (annual): ₹129.0 Cr
Net profit (annual): ₹19.04 Cr
P/E (TTM): 24.5×Sector 47.4×
Promoter holding: 62.46%-0.39% QoQ
FII holding: 4.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

9 Jun 2026 15:31 IST BSE

Trident Lifeline Merger & Restructuring

Trident Lifeline Limited's stake in subsidiary Trident Mediquip Limited diluted from 59.17% to 58.84%. The change follows the subsidiary's private placement of shares to other investors.

Read the filing ↗